REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
28/04/2025
Voltar para busca
Dado oficial do USPTO
SOURCEPHLEX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SOURCEPHLEX
ST13
US500000079246041Classe
35, 42, 44, 45
Pedido
79246041
Registro
6039116
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
29/04/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42, 44, 45
Data de depósito
12/01/2018
Data de registro
28/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/04/2020
Última transação
29/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
DE
Examinador
LAVACHE, LINDA
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
PharmaLex GmbH
Representantes
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Advertising servicesbusiness management for others; company administration servicesbusiness administration services; providing office functions; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy in the context of the retailing and wholesaling of medicines; providing of outsourcing services in the field of medicine authorisationproductionsalesafety and monitoring
Classe 42
Scientific and technological services and research and design relating theretoscientific researchlaboratory research in the field of pharmaceuticals; industrial analysis and research services in the field of pharmaceuticals; scientific research and development of new products for others in the field of pharmaceuticals; provision of scientific surveysmedical research surveys; development of a web application for inputting and using informative texts for medicines and medical productsin particular user guidespackaging insertsspecialist informationfor providing various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; research in relation to scientific work; preparation of scientific analysis and assessments; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology services for the pharmaceutical and healthcare industriesinformation technology consulting services; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticalspharmaceutical product evaluation; scientific analysis and evaluation of product design; scientific analysis and evaluation of product development; quality control testing; materials testing and evaluation; product safety testing; quality control servicestestinganalysis and evaluation of the goods of others to determine conformity with certification standards; quality testing of products to determine conformity with certification standards; assistance and consultancy in the nature of pharmaceutical research in the field of medicine safety and monitoring; pharmaceutical drug development consultancy in the field of medicine safety
Classe 44
Medical and veterinary medical services; pharmacy adviceprovision of pharmaceutical advice for pharmaceutical and medical device companies; providing information relating to the preparation and dispensing of medications
Classe 45
Public document filing assistance in the field of medicine authorizationpublic document filing services pertaining to documents for authorizing medicines featuring documentsreports and files required by regulatory authorities; regulatory compliance consultancy in the field of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/11/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/11/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/09/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/09/2020
FIMP
FINAL DISPOSITION PROCESSED
01/09/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/07/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
22/05/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
28/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/04/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
22/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/02/2020
PUBO
PUBLISHED FOR OPPOSITION
11/02/2020
GPNX
NOTIFICATION PROCESSED BY IB
07/02/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/12/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
16/12/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
16/07/2019
GNFR
FINAL REFUSAL E-MAILED
16/07/2019
CNFR
FINAL REFUSAL WRITTEN
16/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/06/2019
ALIE
ASSIGNED TO LIE
14/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/06/2019
RFNT
REFUSAL PROCESSED BY IB
28/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/12/2018
RFRR
REFUSAL PROCESSED BY MPU
11/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
30/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/11/2018
CNRT
NON-FINAL ACTION WRITTEN
28/11/2018
DOCK
ASSIGNED TO EXAMINER
26/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SOURCEPHLEX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.